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Summary
It is now thought that atherosclerosis, although due to increased
plasma lipids, is mainly the consequence of a complicated inflam-
matory process, with immune responses at the different stages of
plaque development. Increasing evidence points to a significant
role of Toll-like receptor 4 (TLR4), a key player in innate immunity,
in the pathogenesis of atherosclerosis. This study aimed to
determine the effects on TLR4 activation of two reactive oxidized
lipids carried by oxidized low-density lipoproteins, the oxysterol
27-hydroxycholesterol (27-OH) and the aldehyde 4-hydroxynone-
nal (HNE), bothofwhich accumulate in atherosclerotic plaques and
play a key role in the pathogenesis of atherosclerosis. Secondarily,
it examined their potential involvement in mediating inflamma-
tion and extracellular matrix degradation, the hallmarks of high-
risk atherosclerotic unstable plaques. In human promonocytic
U937 cells, both 27-OHandHNEwere found to enhance cell release
of IL-8, IL-1b, and TNF-a and to upregulate matrix metalloprotein-
ase-9 (MMP-9) via TLR4/NF-jB-dependent pathway; these actions
may sustain the inflammatory response and matrix degradation
that lead to atherosclerotic plaque instability and to their rupture.
Using specific antibodies, it was also demonstrated that these
inflammatory cytokines increase MMP-9 upregulation, thus
enhancing the release of this matrix-degrading enzyme by macro-
phage cells and contributing to plaque instability. These innova-
tive results suggest that, by accumulating in atherosclerotic
plaques, the two oxidized lipids may contribute to plaque insta-
bility and rupture. Theyappear todosoby sustaining the releaseof
inflammatorymolecules andMMP-9 by inflammatory and immune
cells, for example,macrophages, throughactivationof TLR4and its
NF-jB downstream signaling.
Key words: atherosclerosis; 27-hydroxycholesterol; 4-hydroxy-
nonenal; TLR4; cytokines; MMP-9.
Introduction
Atherosclerosis is a multifactorial disease characterized by the accumu-
lation of lipids in the vascular wall. Although increased plasma lipids are
central to the development of atherosclerosis, this disease is now mainly
thought to be the consequence of a complex inflammatory process,
involving immune responses at the initiation and progression of the
atherosclerotic lesion, as well as at the time of plaque instability
(Hansson, 2001; Steinberg, 2002). Several studies have suggested that
atherogenesis is dependent on the innate immune response and that
monocytes/macrophages, as well as T lymphocytes, all of which are
cellular components of innate immunity, play predominant roles in
atherosclerosis. Activation of these immune cells leads to a cascade of
pro-inflammatory molecules release, which induces an inflammatory
state in the vessel wall, with subsequent activation of the other arterial
wall cells. Further, macrophages express receptors that recognize
molecular patterns commonly found on pathogens (PAMPs: pathogen-
associated molecular patterns) but foreign to mammalian organisms and
are important in innate immunity. In this context, the type I transmem-
brane receptors known as Toll-like receptors (TLRs) are the innate
immune receptors that have been most extensively studied and
characterized. TLRs, however, are not only expressed on macrophages
but also on the other cells commonly found in the arterial wall
(Seneviratne et al., 2012).
A variety of exogenous and endogenous ligands can activate TLRs by
binding the extracellular domain: This activation induces dimerization of
the receptor and binding of either the adaptor protein myeloid
differentiation factor 88 (MyD88) or the TIR domain-containing adaptor
inducing interferon-b (TRIF)-dependent pathway, which process culmi-
nates in interferon-regulating factor 3 (IRF3) activation. Indeed, TLRs
require either the MyD88-dependent (all TLRs except TLR3) or the TRIF-
dependent (TLR4 and TLR3) pathway to initiate downstream signaling.
This then leads to mitogen-activated protein kinases (MAPKs) and
nuclear factor-jB (NF-jB) activation, with consequent release of a variety
of inflammatory molecules, thus augmenting the local inflammatory
response and/or matrix breakdown. TLRs, thus, play a crucial role in the
initiation of an innate immune response through activation of the
inflammatory cells via NF-jB-dependent pathway and in the subsequent
activation of the adaptive immune response (Jeong & Lee, 2011; Bijani
et al., 2012).
There is increasing evidence to support the involvement of TLRs,
mainly TLR2 and TLR4, in the initiation, progression, and instability of
atherosclerotic lesions, leading to plaque rupture (Edfeldt et al., 2002;
Vink et al., 2004; Schoneveld et al., 2008; Curtiss & Tobias, 2009;
Seneviratne et al., 2012; Cole et al., 2013), as well as their involvement
in other cardiovascular diseases (Bijani et al., 2012). However, their
functional role in human atherosclerosis is still unclear.
TLR4 overexpression has been reported in both human and mouse
atherosclerotic lesions, mainly in macrophages and endothelial cells
(ECs) within the lesion, at different stages of atherogenesis (Xu et al.,
2001; Edfeldt et al., 2002; Vink et al., 2002; Pasterkamp et al., 2004;
Miller et al., 2009; den Dekker et al., 2010). Activation of TLR4
upregulates the expression of various cytokines, chemokines, and
adhesion molecules involved in cell recruitment and proliferation, thus
initiating the inflammatory response and promoting intimal foam cell
accumulation. However, although the role of TLR4 is well established
in the early phase and in the progression of atherosclerosis, as shown
by studies in knockout mice (Bj€orkbacka et al., 2004; Michelsen et al.,
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2004; Higashimori et al., 2011), its role in advanced and unstable
atherosclerotic plaques has yet to be fully assessed, and few studies
point to an association between TLR4 activation and plaque rupture
(Methe et al., 2005; Geng et al., 2006; Ishikawa et al., 2008). TLR4
has been shown to be important in the process of expansive arterial
remodeling and in matrix breakdown; the latter process involves cell
migration and leads to higher expression levels of matrix metallopro-
teinases (MMPs), mainly MMP-2 and MMP-9, which are involved in
extracellular matrix (ECM) degradation (Hollestelle et al., 2004).
Alongside the classic endogenous ligands, the endogenously pro-
duced TLR ligands most relevant to the context of atherosclerosis are the
minimally modified low-density lipoproteins (mmLDLs) and the oxidized
LDLs (oxLDLs), together with their active components; these include
oxidized phospholipids, cholesterol oxidation products (oxysterols), and
free and esterified aldehydes.
It has been demonstrated that both mmLDLs and oxLDLs activate
murine and human monocytes and macrophages during inflammatory
processes, in a mechanism involving TLR2 and TLR4, and that they
increase the expression of these receptors so as to enhance and sustain
pro-inflammatory molecule production (Xu et al., 2001; Chavez-Sanchez
et al., 2010).
Among the oxidized lipids carried by oxLDLs, cholesterol oxidation
products, including the most abundant circulating oxysterol 27-hydroxy-
cholesterol (27-OH), and one of the more reactive end products of lipid
peroxidation, namely 4-hydroxynonenal (HNE), play a key role in the
pathogenesis of atherosclerosis by stimulating various signal transduc-
tion pathways, involved in the immune and inflammatory response as
well as in oxidative stress. These are all important events that contribute
to enhancing MMP production and activation, resulting in excessive
matrix degradation and the rupture of vulnerable atherosclerotic plaques
(Leonarduzzi et al., 2005; Poli et al., 2009; Gargiulo et al., 2011). Of
note, among the various MMPs, MMP-9 has been consistently implicated
in the pathophysiology of plaque rupture, and various inflammatory
molecules, in particular interleukin-6 (IL-6), IL-8, IL-1b, and tumor
necrosis factor-a (TNF-a), play crucial roles in the cross talk between
vascular cells leading to upregulated MMP expression (Moreau et al.,
1999; Lu et al., 2012; Zhong et al., 2014).
Within this framework, the objective of this study on human
promonocytic U937 cells was to examine the effects of the oxysterol
27-OH and the unsaturated aldehyde HNE on TLR4 activation. These
two oxidized lipids, which have important pathophysiological actions
in vivo, are consistently involved in the pathogenesis of atheroscle-
rosis due to their substantial accumulation in the atherosclerotic
plaque where they act as potent inducers of inflammatory gene
expression (Leonarduzzi et al., 2005; Poli et al., 2008, 2009; Sottero
et al., 2009). Moreover, in our previous study, 27-OH was found to
be the principal oxysterol responsible for the MMP-9 upregulation
(Gargiulo et al., 2011). It also looked at the potential involvement of
TLR4 in mediating inflammation and matrix degradation during the
progression of atherosclerosis. Both oxidized lipids were found to
enhance the release of IL-8, IL-1b, and TNF-a and to upregulate
MMP-9, via TLR4/NF-jB-dependent pathway, thereby augmenting
both inflammatory response and matrix degradation, which lead to
atherosclerotic plaque instability and eventually rupture. Given that
an inflammatory state can contribute to MMP production, it is of
note that using specific antibodies, it was also demonstrated that
these inflammatory cytokines act on MMP-9, upregulating its
expression and synthesis, thus sustaining the release of this matrix-
degrading enzyme by vascular cells, and contributing to plaque
instability.
Results
Activation of TLR4 and NF-jB by 27-hydroxycholesterol and
4-hydroxynonenal in U937 cells
To investigate whether 27-OH and HNE affect the activation of TLR4,
human promonocytic U937 cells were incubated with these two
components of oxLDLs. The oxysterol 27-OH was used at 6 lM, a
concentration mimicking the amount of this oxysterol found in
atherosclerotic plaques (Leonarduzzi et al., 2007), while HNE was used
at a concentration of 5 lM, which is below that found in inflamed and
diseased tissues (Esterbauer et al., 1991), to avoid alteration and/or
inhibition of various cellular responses (Poli et al., 2008). Moreover, at
these concentrations, these compounds were not cytotoxic as demon-
strated by MTT analysis and trypan blue exclusion test (data not
shown).
The effects of 27-OH and HNE on TLR4 expression were quantified
by real-time RT–PCR. An approximately time-dependent increase of
TLR4 mRNA levels was observed from 2 to 6 h of treatment, compared
with untreated cells (control). Both oxidized lipids significantly induced
TLR4 expression after 6-h cell treatment (Fig. 1A). An increase of TLR4
protein levels was observed by immunofluorescence and by Western
blotting analysis after 6-h cell incubation with either 27-OH or HNE
(Fig. 1B).
Because TLR4 is a key inducer of the NF-jB pathway, which is one of
the principal inflammatory signals, the relationship between TLR4 and
NF-jB signaling pathways was investigated. One of the key events in NF-
jB activation involves phosphorylation of IjB followed by nuclear
translocation of p65, a subunit of the NF-jB complex. Nuclear
translocation of the p65 subunit was demonstrated by immunofluores-
cence analysis (using a confocal laser microscope) in U937 cells after 3-h
treatment with either 27-OH or HNE. Translocation of p65 into the
nucleus was evident, compared with control cells, in both cases, but was
more pronounced after 27-OH cell incubation (Fig. 1C). To verify the
relationship between TLR4 and NF-jB signaling pathways, cells were
incubated with 27-OH or HNE in the presence (co-treatment) of an anti-
TLR4 antibody (0.2 lg mL-1). By blocking the TLR4 pathway, nuclear
translocation of p65, as downstream signaling, was fully inhibited
(Fig. 1C).
Upregulation of IL-8, IL-1b, and TNF-a by 27-OH and HNE
Among the inflammatory cytokines involved in the pathogenesis of
atherosclerosis and associated with matrix degradation, the effect of
6 lM 27-OH and 5 lM HNE on IL-8, TNF-a, and IL-1b expression and
protein levels were checked in U937 cells, by quantitative RT–PCR for up
to 8-h treatment and by Bio-Plex system after 24-h treatment,
respectively.
The expression of IL-8 was significantly increased by 27-OH after 2-
and 6-h treatment, while HNE induced IL-8 expression in a significant
manner at all the times examined (Fig. 2A). The protein levels of this
inflammatory cytokine were also found to be markedly higher in cells
treated for 24 h with 27-OH or with HNE, compared with untreated cells
(control) (Fig. 2B). Regarding IL-1b, both 27-OH and HNE induced
expression of the cytokine at all times investigated, but the increase was
only significant after 6-h cell treatment (Fig. 2C); data obtained with the
Bio-Plex system indicate that only 27-OH significantly increased IL-1b
protein levels after 24-h treatment (Fig. 2D). Lastly, expression of TNF-a
was significantly induced by 27-OH at 6 h of incubation and by HNE in a
time-dependent manner but with a significant increase at 6 and 8 h of
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incubation (Fig. 2E). Protein levels of TNF-a were induced by both 27-OH
and HNE (Fig. 2F).
Down-regulation of the inflammatory cytokines by inhibiting
the TLR4/NF-jB signaling pathway
TLR4 plays an important role in the inflammatory signaling responses to
various stimuli, leading to the transcription, via NF-jB-dependent
pathway, of a variety of genes involved in inflammation.
To investigate the key association between activation of the TLR4/NF-
jB pathway and cytokine upregulation, U937 cells were treated for 6 h
(time point at which cytokine expression was consistently induced by
both oxidized lipids) or for 24 h, with 6 lM 27-OH or with 5 lM HNE, in
the presence or absence of an antibody directed against TLR4. To
support the involvement of TLR4 in the inflammation process induced by
27-OH and HNE, the effect of TLR4 gene knockdown using a specific
small interfering RNA (siRNA) was also investigated after 24 h of reverse
transfection, followed by 6-h cell incubation with 27-OH or HNE.
A significant decrease of expression of IL-8 (Fig. 3A,B), IL-1b (Fig. 3C,
D), and TNF-a (Fig. 3E,F) was observed in cells co-treated with an anti-
TLR4 antibody (0.2 lg mL-1) as well as in cells transfected with a TLR4
siRNA, compared with cells treated with 27-OH or with HNE. Observa-
tion was carried out by real-time RT–PCR. Cell incubation with the anti-
TLR4 antibody alone did not affect cytokine expression; cell transfection
with a negative control (scramble siRNA) demonstrated a specific effect
on gene expression of TLR4 siRNA. A marked and significant decrease of
protein levels of IL-8 (Fig. 4A,B), IL-1b (Fig. 4C,D), and TNF-a (Fig. 4E,F)
was also observed in cells incubated with an anti-TLR4 antibody
(0.2 lg mL-1). Observation was carried out by ELISA and immunofluo-
rescence analysis using a confocal laser microscope.
To test experimentally the involvement of the transcription factor
NF-jB in the modulation of these inflammatory cytokines, other cells
were pretreated (1 h) with 1 lM parthenolide (PTN), a specific inhibitor
of NF-jB. Blocking NF-jB nuclear translocation with parthenolide
caused a significant decrease in IL-8, IL-1b, and TNF-a expression, in
cells treated for 6 h with either 27-OH or HNE (Fig. 5A,C,E). Cell
incubation with PTN alone did not affect cytokine expression. An
evident decrease of protein levels of these inflammatory molecules was
also detected by ELISA (Fig. 5B,D,F) and confocal microscopy (Fig. 6)
after cell pretreatment with PTN followed by cell incubation with 27-
OH or HNE for 24 h.
Upregulation of MMP-9 by 27-OH and HNE in U937 cells via
TLR4/NF-jB-dependent pathway
The effects of 27-OH (6 lM) and HNE (5 lM) on MMP-9 expression and
synthesis were checked by quantitative RT–PCR after 24-h treatment and
by ELISA after 48-h treatment, respectively. Of note, the ELISA kit
employed recognizes both inactive and active forms of MMP-9. In
human promonocytic U937 cells, MMP-9 expression (Fig. 7A) and
protein levels (Fig. 7B) were consistently induced both by the oxysterol
and by the lipid aldehyde, compared with untreated cells (control).
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Fig. 1 Activation of TLR4/NF-jB pathway by 27-OH and HNE in U937 cells. Cells were incubated with 6 lM 27-OH or 5 lM HNE. (A) TLR4 expression was quantified after
incubation with 27-OH or HNE by real-time RT–PCR for up to 6 h. Data are means  SD of four experiments and are expressed as fold induction vs. control (untreated cells).
***P < 0.001 and *P < 0.05 vs. control. (B) After cell treatment for 6 h, TLR4 protein levels were detected by confocal laser microscopy using a TRITC-conjugated secondary
antibody (532-nm exciting laser band, 572-nm long-pass emission filter, and 40x/0.75 lens). The images are representative of three experiments. TLR4 protein levels were
also analyzed by Western blotting after 6-h cell treatment. The blot is representative of two experiments. (C) After cell co-treatment with 0.2 lg mL-1 TLR4 antibody and
with 27-OH or HNE for 3 h, cytoplasmic and nuclear localization of p65, a subunit of NF-jB, was visualized by confocal laser microscopy using a FITC-conjugated secondary
antibody (488-nm exciting laser band and emission passing through a long-pass 505-550 filter, lens 40x/0.75). The images are representative of three experiments.
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As supported by other studies, MMP-9 release can be regulated via
TLR4/NF-jB-dependent pathway (Ikeda & Funaba, 2003; Gebbia
et al.,2004; Li et al., 2012; Paolillo et al., 2012).
The involvement of TLR4 in MMP-9 upregulation induced by 27-OH
and HNE was investigated by blocking the receptor with a specific anti-
TLR4 antibody and by TLR4 knockdown using a specific siRNA. Co-
treatment of U937 cells with an anti-TLR4 antibody significantly
decreased both mRNA (Fig. 7C) and protein (Fig. 7D) levels of MMP-9,
as shown by quantitative RT–PCR and ELISA, respectively. To clarify
involvement of the TLR4/NF-jB signaling pathways in the MMP-9
upregulation, other cells were also pretreated with 1 lM parthenolide
(PTN). Pretreatment of U937 cells with this specific inhibitor of NF-jB
nuclear translocation clearly and significantly decreased both expression
(Fig. 7C) and protein levels (Fig. 7D) of MMP-9, induced by 27-OH and
HNE. Cell incubation with the anti-TLR4 antibody or PTN alone did not
affect the expression of MMP-9, compared with untreated cells. To
support the involvement of TLR4 in MMP-9 expression, cells were
transfected for 24 h with a specific TLR4 siRNA: A significant decrease of
MMP-9 expression was found in U937 cells treated with both 27-OH and
HNE for 24 h following TLR4 gene knockdown (Fig. 7E). Cell transfec-
tion with a negative control (scramble siRNA) demonstrated a specific
effect on gene expression of MMP-9 siRNA.
These data support the potential role of TLR4/NF-jB-dependent
pathway in MMP-9 upregulation and subsequently in arterial remodeling
and plaque instability.
Involvement of inflammatory cytokines on MMP-9
upregulation
Besides the potential direct upregulation of MMP-9 through the TLR4/
NF-jB-dependent pathway, as suggested by the above results, tran-
scription of the MMP-9 gene might also be stimulated by inflammatory
cytokine release following NF-jB activation, thus contributing to
atherosclerotic plaque instability and rupture.
To investigate this hypothesis, the action of IL-8, IL-1b, and TNF-a,
which are released following cell treatment with 6 lM 27-OH and 5 lM
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HNE, was blocked with specific antibodies; both MMP-9 mRNA (Fig. 8A)
and protein (Fig. 8B) levels were consistently decreased, confirming the
importance of these cytokines in regulating the protease levels induced
by 27-OH and HNE.
Discussion
In the present study, we first demonstrated the effects of the oxysterol
27-OH and the unsaturated aldehyde HNE on TLR4 activation in human
promonocytic U937 cells; both oxidized lipids accumulate in atheroscle-
rotic plaques and play a key role in the pathogenesis of atherosclerosis.
We also demonstrated the potential involvement of the TLR4/NF-jB
signaling pathway in mediating inflammation and matrix degradation,
thus contributing to atherosclerotic plaque instability and eventually
rupture. 27-OH and HNE were indeed found to enhance the release of
IL-8, IL-1b, and TNF-a and to upregulate MMP-9, via TLR4/NF-jB-
dependent pathway. These data support the potential role of TLR4 and
its NF-jB downstream signaling in inflammatory cytokines and MMP-9
upregulation, and subsequently in plaque instability.
In this connection, an increasing body of evidence points to an
important role of TLRs in the pathogenesis of atherosclerosis. Arterial
wall cells (mainly ECs, macrophages, and smooth muscle cells) consti-
tutively express TLRs, whereas in the same cells, the expression of TLRs is
upregulated in the presence of hyperlipidemia (Edfeldt et al., 2002;
Schoneveld et al., 2008; Seneviratne et al., 2012). Among the key
players in innate immunity and inflammatory signaling responses to
exogenous and endogenous stimuli, TLR4 appears potentially involved in
this multifactorial disease.
IL
-8
fo
ld
in
du
ct
io
n
(n
or
m
al
iz
ed
to
β-a
ct
in
)
6 h
0
1
2
3
4
**
§
**
§
IL
-1
βf
ol
d
in
du
ct
io
n
(n
or
m
al
iz
ed
to
β-a
ct
in
)
***
§
§
*
0
1
2
3
4
TN
F-
α
fo
ld
in
du
ct
io
n
(n
or
m
al
iz
ed
t o
β-a
ct
in
)
*
§
*
§
0
1
2
3
4
(A)
(C)
(E)
(B)
(D)
(F)
27-OH
Anti-TLR4 Ab
HNE
27-OH
Anti-TLR4 Ab
HNE
27-OH
Anti-TLR4 Ab
HNE
IL
-8
fo
ld
in
du
ct
i o
n
(n
o r
m
a l
iz
e d
to
β-a
ct
in
)
6 h
0
1
2
3
4 **
**
27-OH
TRL4 siRNA
HNE
5
** **
##
Scramble siRNA
0
1
2
3
***
**
27-OH
TRL4 siRNA
HNE
***
*
#
Scramble siRNA
IL
-1
βf
ol
d
in
du
ct
io
n
(n
or
m
al
iz
e d
to
β-a
ct
in
)
##
0
1
2
3
**
**
27-OH
TRL4 siRNA
HNE
**
**#
Scramble siRNA
##
TN
F-
α
fo
l d
in
du
ct
io
n
(n
or
m
al
iz
ed
to
β-a
ct
in
)
– – + + – –
– – – – + +
+ – + +––
– + + + – – –
– – – – + + +
+ – – + – –
– – + – – +–
–
– + + + – – –
– – – – + + +
+ – – + – –
– – + – – +–
–
– + + + – – –
– – – – + + +
+ – – + – –
– – + – – +–
–
– – + + – –
– – – – + +
+ – + +––
– – + + – –
– – – – + +
+ – + +––
#
Fig. 3 Blocking TLR4 activation negatively affects expression of IL-8, IL-1b, and TNF-a genes. U937 cells were either co-treated with 0.2 lg mL-1 TLR4 antibody or
transfected with a specific TLR4 siRNA for 24 h and then incubated with 6 lM 27-OH or 5 lM HNE for 6 h. Scramble siRNA (negative control) corresponds to a siRNA with
nonspecific sequence. Expression of (A,B) IL-8, (C,D) IL-1b, and (E,F) TNF-a was analyzed by quantitative RT–PCR. The histograms represent the means values  SD of three
experiments. ***P < 0.001, **P < 0.01, and *P < 0.05 vs. control; §P < 0.05 vs. 27-OH or HNE; ##P < 0.01 and #P < 0.05 vs. 27-OH or HNE.
Oxidized lipids, TLR4, and plaque instability, S. Gargiulo et al. 5
ª 2015 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
TLR4 over-expression has been described in human and mouse
atherosclerotic lesions at different stages of atherogenesis in cells
commonly found in the arterial wall, but especially in macrophages
and ECs (Xu et al., 2001; Edfeldt et al., 2002; Vink et al., 2002;
Pasterkamp et al., 2004; Miller et al., 2009; den Dekker et al., 2010).
Supporting evidence for the role of TLRs in plaque progression and
instability was found in a study on double knockout mice for
apolipoprotein E (ApoE) and MyD88. After being fed a cholesterol-
rich diet, the mice showed a reduction in aortic atherosclerosis of
almost 55%: Lesion size, number of macrophages/foam cells, and lipid
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27-OH or 5 lM HNE. Protein levels of (A) IL-8, (C) IL-1b, and (E) TNF-a were analyzed using the ELISA method. Cytokine concentrations (pg mL-1) were extrapolated from the
standard curve. The histograms represent the mean values  SD of three experiments. **P < 0.01 and *P < 0.05 vs. control; §§§P < 0.001, §§P < 0.01, and §P < 0.05 vs.
27-OH or HNE. Immunopositive cells were detected by confocal laser microscopy: (B) IL-8 and (D) IL-1b using a TRITC-conjugated secondary antibody (532-nm exciting laser
band, 572-nm long-pass emission filter, and 40x/0.75 lens); (F) TNF-a using a FITC-conjugated secondary antibody (488-nm exciting laser band and emission passing through
a long-pass 505-550 filter, lens 40x/0.75). The images are representative of three experiments.
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content in aortic plaques, as well as circulating inflammatory
molecules, were all markedly reduced compared with ApoE/ and
MyD88+/+ mice. Thus, in ApoE/ and MyD88/ mice, not only was
the atherosclerotic lesion reduced, but the plaque phenotype was also
altered. Of note, the major effect of MyD88 deletion on activated
macrophage was at the level of pro-inflammatory molecule expression
(Bj€orkbacka et al., 2004; Michelsen et al., 2004; Higashimori et al.,
2011). In another study, double knockout mice for ApoE and TLR4
(ApoE//TLR4/) also showed markedly reduced atherosclerosis and
altered plaque phenotype, despite persistent hypercholesterolemia
(Michelsen et al., 2004). Collectively, these results indicate that
inactivation of TLR4/MyD88-dependent signaling strongly inhibits
development of atherosclerosis and promotes a more stable plaque
phenotype, mainly by reducing inflammatory molecule release as a
consequence of NF-jB inactivation.
TLR gene polymorphisms have also been studied in connection with
atherosclerotic vascular disease. The Asp299Gly polymorphism in TLR4
has been associated with a lower risk of carotid atherosclerosis, and a
reduction in intima media thickness in the common carotid artery (Kiechl
et al., 2002; Hernesniemi et al., 2008), and has also been linked to
decreased acute coronary events, and greater efficacy of statin therapy
(Ameziane et al., 2003; Boekholdt et al., 2003). However, conflicting
reports have also been published, showing that the presence or the
absence of the Asp299Gly polymorphism is not associated with
predisposition to, or progression of, atherosclerotic lesions in patients
with hypercholesterolemia (Netea et al., 2004).
TLR4 has also been shown to be important in the process of expansive
arterial remodeling and in ECM degradation leading to higher expression
levels of MMPs, mainly the matrix-degrading enzymes MMP-2 and
MMP-9 (Hollestelle et al., 2004). TLR4 can act by stimulating macro-
phages to produce MMPs, contributing to fibrous cap thinning, or
leading to smooth muscle cell (SMC) apoptosis; this reduces ECM
production and subsequently weakens the fibrous cap and causes plaque
rupture. In this context, patients with acute coronary syndromes or
coronary arteriosclerosis showed increased TLR4 expression on circulat-
ing monocytes, compared with control patients (Methe et al., 2005;
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Fig. 5 Effect of NF-jB inhibition on
cytokine expression and protein levels.
U937 cells were pretreated for 1 h with
1 lM parthenolide (PTN) and then with
6 lM 27-OH or 5 lM HNE. Expression of (A)
IL-8, (C) IL-1b, and (E) TNF-a was analyzed
by real-time RT–PCR after 6-h cell
incubation with 27-OH or HNE. The
histograms represent the mean values  SD
of five experiments. **P < 0.01 and
*P < 0.05 vs. control; §P < 0.05 vs. 27-OH
or HNE. Protein levels of (B) IL-8, (D) IL-1b,
and (F) TNF-a were quantified by ELISA
after 24-h cell incubation. Cytokine
concentrations (pg mL-1) were extrapolated
from the standard curve. The histograms
represent the mean values  SD of three
experiments. **P < 0.01 and *P < 0.05 vs.
control; §§P < 0.01 and §P < 0.05 vs. 27-
OH or HNE.
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Geng et al., 2006); high expression of TLR4 was also found at the site of
ruptured plaques in patients with acute myocardial infarction (Ishikawa
et al., 2008).
In light of these findings, because atherosclerotic plaque instability is
associated with the presence in the plaque of inflammatory cells
producing pro-inflammatory cytokines and MMPs, causing matrix
turnover, and because TLR4 is associated with both inflammation and
matrix breakdown, TLR4 signaling appears to be important in plaque
progression and instability, and in the subsequent plaque rupture.
In the context of atherosclerosis, during which inflammatory events
are accompanied by oxidative stress, alongside the classic endogenous
ligands, oxidized lipids also appear to be capable of activating TLR4 and
of modulating an inflammatory response. In this connection, it has been
shown that mmLDLs and their active components can trigger cytoskel-
etal rearrangements dependent on TLR4, which lead to enhanced
uptake of lipoproteins by macropinocytosis, in turn leading to intracel-
lular lipid accumulation (Choi et al., 2009); alternatively, these lipid
compounds can contribute to early-stage intimal foam cell formation, by
increasing the expression of scavenger receptors (Doyle et al., 2004). In
addition, it has been shown in vivo that endothelial adhesion and
recruitment of macrophages and other leukocytes in response to
mmLDLs are impaired in the absence of MyD88 (Michelsen et al.,
2004). Moreover, mmLDLs induce TLR4-dependent and TLR4-indepen-
dent cytokine secretion from macrophages (Miller et al., 2005); they
have also been reported to induce IL-1b, IL-6, and IL-10 secretion in
human monocytes and macrophages, in a process involving activation of
TLR2 and TLR4 (Chavez-Sanchez et al., 2010). Regarding oxLDLs, it has
been found that they induce upregulation of TLR4 expression and its
signaling pathway, in human monocytes/macrophages in vitro, contrib-
uting to the TLR4-dependent lipid accumulation and inflammatory
process in the arterial wall (Xu et al., 2001; Yang et al., 2011). In
patients with unstable angina, oxLDLs may contribute to monocyte
overproduction of some cytokines and above all to that of IL-6 and IL-1b,
by upregulating TLR4 expression (Fratta Pasini et al., 2007). Moreover,
activation of the receptors TLR4 and CD36 by oxLDLs in macrophages
induces secretion of various cytokines and foam cell formation (Chavez-
Sanchez et al., 2014). It has also been shown that oxLDLs regulate the
expression of various inflammatory cytokines via the TLR4/NF-jB
pathway in arterial SMCs from wild-type mice. This effect was
significantly weakened in cells derived from TLR4 knockout mice (Yang
et al., 2014).
Because mmLDLs and oxLDLs act as endogenous ligands of TLR4, we
can speculate that, among the various oxidized lipids carried by mmLDLs
or oxLDLs, the principal agents of TLR4 activation, promoting inflam-
matory molecule release, might be oxysterols, unsaturated aldehydes,
and oxidized phospholipids. Nowadays, however, few studies have
addressed this point and those that have report contradictory results. For
example, in aortic ECs, oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-
3-phosphorylcholine (oxPAPC), one of the main phospholipids of LDL,
has been suggested to increase the expression of IL-8, a chemokine
important in monocyte recruitment, acting through TLR4 (Walton et al.,
2003a); contemporarily, the same research group noted that specific
oxidation products of oxPAPC may inhibit chemokine induction by TLR4
and TLR2 ligands, in ECs and macrophages (Walton et al., 2003b). In
primary neuronal cultures, HNE was found to increase TLR4 signaling
inducing the degeneration of neurons to amyloid-b and oxidative stress
(Tang et al., 2008). In contrast, in human macrophage THP-1, the
oxysterols 25-OH, 7b-OH, and 7-ketocholesterol may contribute to
increasing expression of certain pro-inflammatory cytokines, principally
IL-8, but this occurs by mechanisms that are independent of TLR
signaling, including TLR4 (Erridge et al., 2007). Moreover, in another
study, HNE was showed to suppress the activation of signaling pathways
and gene expression induced by TLR4 agonist resulting in down-
regulation of the phagocytic activity of macrophages (Kim et al., 2009).
These contradictory results could depend on different cell types, oxidized
lipids, and concentrations used.
In light of these findings, the present study aimed to determine the
effect on TLR4 activation of 27-OH, reported to be the principal oxysterol
responsible for the MMP-9 upregulation (Gargiulo et al., 2011) and that
of HNE, one of the most reactive unsaturated aldehydes derived from
polyunsaturated fatty acid oxidation (Esterbauer et al., 1991). These two
oxidized lipids are consistently involved in the pathogenesis of athero-
sclerosis, because they accumulate in the atherosclerotic plaque in
considerable amounts and are potent inducers of oxidative stress and
inflammatory events (Leonarduzzi et al., 2005; Poli et al., 2009).
Moreover, given the crucial role of inflammatory cytokines and MMPs
Control 27-OH 6 μM
27-OH 6 μM +
PTN 1 μM HNE 5 μM
HNE 5 μM +
PTN 1 μM
IL-8
IL-1β
TNF-α
24 h
Fig. 6 NF-jB inhibition decreases cytokine
levels. U937 cells were pretreated for 1 h
with 1 lM parthenolide (PTN) and then
incubated with 6 lM 27-OH or 5 lM HNE
for 24 h. Immunopositive cells were
detected by confocal laser microscopy: IL-8
and IL-1b using a TRITC-conjugated
secondary antibody (532-nm exciting laser
band, 572-nm long-pass emission filter,
and 40x/0.75 lens); TNF-a using a FITC-
conjugated secondary antibody (488-nm
exciting laser band and emission passing
through a long-pass 505-550 filter, lens
40x/0.75). The images are representative of
three experiments.
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in plaque rupture, it was also decided to clarify involvement of the TLR4/
NF-jB-dependent signaling pathway, activated by 27-OH and HNE, in
promoting IL-8, IL-1b, and TNF-a, as well as in MMP-9 production, in
human promonocytic U937 cells. Both 27-OH and HNE enhanced
expression and protein levels of TLR4 and induced the nuclear
translocation of the transcription factor NF-jB, as TLR4 downstream
signal (Fig. 1). Activation of NF-jB is essential for the regulation of a
variety of genes that are involved in the inflammatory responses of cells
critical to atherogenesis. The effects exerted by 27-OH and HNE on the
TLR4/NF-jB signaling pathway significantly promoted expression and
protein levels of IL-8, IL-1b, and TNF-a, that is, cytokines involved in
plaque instability, as was clearly demonstrated using an antibody against
TLR4 or TLR4 siRNA (Figs 3 and 4), or parthenolide, an inhibitor of NF-jB
nuclear translocation (Fig 5 and 6). Because TLR4 may contribute to
matrix breakdown, leading to higher expression levels of MMPs, it was
then investigated whether 27-OH and HNE might upregulate MMP-9,
which is consistently implicated in the pathophysiology of plaque
instability and rupture, via TLR4/NF-jB-dependent pathway. Both
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pretreated with 1 lM parthenolide (PTN) and then incubated with 6 lM 27-OH or 5 lM HNE for 24 h. The histograms represent the mean values  SD of three experiments.
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compounds markedly induced expression and protein levels of MMP-9,
the induction being significantly lessened upon using an anti-TLR4
antibody or TLR4 siRNA, or the inhibitor (parthenolide) of NF-jB (Fig. 7).
These observations clearly indicate that 27-OH and HNE are able to
promote production of the inflammatory cytokines studied here, and of
MMP-9, through the TLR4/NF-jB signaling pathway. The results are in
agreement with other studies, for example, in vitro studies have shown
that TLR2 and TLR4 ligation induces the secretion of MMP-9 in
monocytes and mast cells, which are present in the walls of human
coronary arteries (Ikeda & Funaba, 2003; Gebbia et al., 2004). It has also
been demonstrated that activation of TLR4 induces MMP-9 expression in
human aortic SMCs through the TLR4/NF-jB signaling pathway (Li et al.,
2012) and that it has a comparable effect in human umbilical vascular
ECs (Paolillo et al., 2012).
In this study, TLR4 signaling thus appears to be important in plaque
progression and instability, although other signaling pathways may be
activated by lipid oxidation products, and they may be interconnected. In
a previous study, the present authors showed that an oxysterol mixture,
of composition similar to that found in advanced human carotid plaques
(Leonarduzzi et al., 2007), upregulates MMP-9 through a sequence of
events: overproduction of ROS, leading to activation of the MAPK
signaling pathways, via protein kinase C, and enhancement of DNA
binding of NF-jB, and activator protein-1 (AP-1) (Gargiulo et al., 2011).
Further, it is known that an inflammatory state can contribute to MMP
production. Various inflammatory molecules (e.g., IL-1b, IL-8, IL-12, IL-
18, and TNF-a) may operate a control level of MMP production,
regulating their expression at the transcriptional levels and their cell
release. It has been reported that oxLDLs and oxysterols (mainly 25-
hydroxycholesterol) can lead to an imbalance between MMPs and tissue
inhibitors of MP (TIMPs), by inhibiting TIMP-1 expression in macrophag-
es. This inhibition is partially mediated by IL-8 (Moreau et al., 1999). In
this connection, it was observed in this study that the increased
inflammatory cytokines (IL-8, IL-1b, and TNF-a) act on MMP-9 by
upregulating its expression and synthesis, thus sustaining the release by
vascular cells of this matrix-degrading enzyme and contributing to
plaque instability (Fig. 8). In support of these findings, a recent study
reported that activation of the TLR4/NF-jB pathway in microvascular ECs
triggered marked upregulation of inflammatory molecules, which play a
major role in the cross talk between ECs and monocytes/macrophages,
leading to upregulated MMP expression, mainly via IL-6 secretion (Lu
et al., 2012). Moreover, TNF-a induces expression of MMP-2 and MMP-
9 in vascular SMCs, through the NF-jB pathway (Zhong et al., 2014).
Taken together, these data support the important role of 27-OH and
HNE in atherosclerosis instability, and for the first time, we have
demonstrated that these oxidized lipids act as endogenous ligands of
TLR4. The compounds 27-OH and HNE contribute to both inflammation
and matrix breakdown through activation of TLR4 and its downstream
signaling. It thus appears that activation of TLR4 is fundamental for
atherosclerosis due to its participation in the production of inflammatory
cytokines and MMP-9, although other signaling pathways may also be
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involved. These data therefore support the hypothesis that atheroscle-
rosis is a consequence of a complex inflammatory process, in which
immune response might be involved. Moreover, because TLR4/NF-jB
appears to play a predominant role in inflammation and matrix
degradation in atherosclerosis, these observations may provide a
foundation for the development of innovative therapeutic strategies,
such as antagonists of TLR4 or TLR4 siRNAs, for the prevention and
therapy of atherosclerosis and its complications.
Experimental procedures
Cell culture and treatments
The human promonocytic cell line U937 was cultured in RPMI 1640
medium supplemented with 10% fetal bovine serum (Invitrogen, Life
Technologies, Monza, Italy), 100 U mL-1 penicillin, 100 lg mL-1 strep-
tomycin, and 2 mM glutamine (Sigma-Aldrich, Milan, Italy) at 37 °C with
5% CO2. The cells were dispensed at 1 9 10
6/mL and made quiescent
through overnight incubation in serum-free medium. They were then
placed in RPMI 1640 medium with 2% fetal bovine serum and treated
with 6 lM 27-OH (Avanti Polarlipids, Alabaster, AL, USA) or in serum-
free RPMI 1640 medium and treated with 5 lM HNE (Alexis, Vinci-
Biochem, Vinci, Italy). In certain experiments, cells were co-treated with
anti-TLR4 (0.2 lg mL-1), anti-IL-8 (0.04 lg mL-1), anti-IL-1b
(0.04 lg mL-1), or anti-TNF-a (0.04 lg mL-1) antibodies (Santa Cruz
Biotechnology, Santa Cruz, CA, USA). In others cases, cells were
pretreated for 1 h with 1 lM parthenolide (PTN) (Sigma-Aldrich), a
specific inhibitor of NF-jB nuclear translocation. Final concentrations and
incubation times for all experiments are reported in the figure legends.
RNA extraction
Total RNA was extracted from cells using TRIzol reagent (Applied
Biosystems, Life Technologies), following the manufacturer’s instruc-
tions, after treatment for specified times with 27-OH or HNE. RNA was
dissolved in RNase-free water with RNase inhibitors (RNase SUPERase-In;
Ambion, Life Technologies). The amount and purity (A260/A280 ratio) of
the extracted RNA were assessed spectrophotometrically.
cDNA preparation and real-time RT–PCR
cDNA was synthesized by reverse transcription from 2 lg RNA with a
commercial kit and random primers (High-Capacity cDNA reverse
transcription kit; Life Technologies), following the manufacturer’s
instructions. Singleplex real-time RT–PCR was performed on 40 ng of
cDNA using TaqMan gene expression assay kits prepared for human
TLR4, IL-8, IL-1b, TNF-a, MMP-9, and b-actin and TaqMan Fast
Universal PCR master mix, and analyzed by a 7500 Fast real-time PCR
system (Applied Biosystems, Life Technologies). The oligonucleotide
sequences are not revealed by the manufacturer because of proprietary
interests. The cycling parameters were as follows: 20 s at 95 °C for
AmpErase UNG activation, 3 s at 95 °C for AmpliTaq Gold DNA
polymerase activation, and 40 cycles of 3 s each at 95 °C (melting) and
30 s at 60 °C (annealing/extension). The fractional cycle number at
which fluorescence passes the threshold in the amplification plot of
fluorescence signal vs. cycle number was determined for each gene
considered. The results were then normalized to the expression of b-
actin, as housekeeping gene. Target gene expression was quantified
relatively with a mathematical method proposed by Livak & Schmittgen
(2001).
siRNA transfection
Small interfering RNA (siRNA) was used for transient gene knockdown
studies. The siRNAs used were TLR4 s14195 and siRNA #1 for the
negative control (scramble siRNA) (Applied Biosystems, Life Technol-
ogies). Negative control corresponds to a siRNA with nonspecific
sequence. Transfection of TLR4-specific and control siRNAs was
performed following the manufacturer’s instructions. Briefly, 50 nM
of siRNAs was mixed with 25 lL of transfection reagent solution
(NeoFX, Applied Biosystems, Life Technologies) and left at room
temperature for 10 min in RPMI medium with 1% fetal bovine serum
and without antibiotics. After 24 h of reverse transfection, the cells
(4 9 104 500 lL1) were incubated with 27-OH or HNE for 6 or
24 h. For gene expression analysis, total RNA was isolated from the
cells and used for quantitative RT–PCR as described above. The
transfection efficiency, validated by quantitative RT–PCR, was approx-
imately 60%.
Western blotting
Whole-cell extracts were prepared in ice-cold lysing buffer (50 mM
Tris–HCl, pH 7.4, 50 mM NaCl, NP-40 1%, Triton X-100 1%, 0.5 mM
EDTA, sodium deoxycholate 1%) containing protease inhibitors (5 mM
DTT, PMSF 0.1%, aprotinin 1%). Total proteins (65 lg) were
separated by electrophoresis in 8% denaturing SDS/polyacrylamide
gel and then transferred to Hybond ECL nitrocellulose membrane (GE
Healthcare Europe, Milan, Italy). After saturation of nonspecific
binding sites with 5% nonfat milk in Tris-buffered saline (TBS) 1x-
Tween 20 0.05%, the membrane was immunoblotted overnight at
4 °C with the primary antibody against TLR4 (1:500) and subsequently
probed with an anti-goat secondary antibody (1:1000) (Santa Cruz
Biotechnology Inc.,) overnight at 4 °C. The membrane was
stripped (Restore Western Blot Stripping buffer, Pierce Biotechnology,
Rockford, IL, USA) and re-immunoblotted with anti-actin primary
antibody (1:7500) and then with anti-rabbit secondary antibodies
(1:5000) (Santa Cruz Biotechnology Inc.). The immunoreactive bands
were visualized through enhanced chemiluminescence using the
ECL-plus kit (GE Healthcare Europe) following the manufacturer’s
protocol.
Analysis of TLR4, p65, IL-8, IL-1b, and TNF-a by
immunofluorescence and detection by confocal laser
microscopy
After treatments, cells were transferred onto glass slides (8 9 104 cells/
slide) by cytocentrifugation. Specimens were fixed in cold methanol for
10 min and permeabilized with 0.1 M PBS 0.4% Triton X-100 solution.
Cells were then incubated with a 100 mM sodium cyanoborohydride-
reducing agent for 10 min at 37 °C. After blocking nonspecific sites of
binding with 0.1 M PBS containing 5% goat serum, 3% BSA, and 0.3%
Tween 20, for 1 h at room temperature, slides were incubated in the
presence of primary antibodies against TLR4 (1:50), p65 (1:50), IL-8
(1:100), IL-1b (1:50), and TNF-a (1:50) (Santa Cruz Biotechnology) and
then with specific secondary antibodies (1:300) conjugated with
fluorescein isothiocyanate (FITC) or tetramethylrhodamine isothiocya-
nate (TRITC) fluorochromes (Alexa Fluor, Molecular Probes, Life Tech-
nologies). Slides mounted with glycerol and distilled water (1:1) were
observed through an LSM 510 confocal laser microscope (Carl Zeiss SpA,
Arese, Milan, Italy) equipped with an inverted microscope with Plan-
NEOFLUAR lenses (40x/0.75).
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Evaluation of protein levels by Bio-Plex system or ELISA
After treatments, cells were lysed and cytosolic proteins were stored for
protein levels assessment. Protein levels of IL-8, IL-1b, and TNF-a were
measured using a magnetic bead-based assay designed for the simul-
taneous detection of the cytokines, reading in a Bio-Plex system dual
laser instrument (Bio-Rad). Assays were performed following the
manufacturer’s instructions using 50 lg protein lysate per well.
Protein levels of IL-8, IL-1b, TNF-a, and MMP-9 were also quantified
using: Human IL-8 ELISA MAXTM Standard Set (BioLegend, San Diego,
CA, USA) for IL-8, Human IL-1 beta ELISA Ready-SET-Go! (eBioscience,
San Diego, CA, USA) for IL-1b, Human TNF-a Instant ELISA (Bender
MedSystems, Wien, Austria) for TNF-a, and the DuoSet ELISA kit (R&D
System, MN, USA) for MMP-9, following the manufacturer’s instruc-
tions. The plates were read at 450 nm with wavelength correction of
550 nm in a microplate reader (Model 680 Microplate Reader, Bio-Rad,
Hercules, CA, USA).
The protein concentrations were extrapolated from the standard
curve.
Statistical analysis
All values are expressed as means  standard deviation (SD). Statistical
analysis of the data was by one-way ANOVA with Bonferroni’s post-test for
multiple comparisons. Differences with P < 0.05 were considered
statistically significant. Statistical calculations were made with the
GraphPad InStat3 software package (GraphPad Software, San Diego,
CA, USA).
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